Blend Labs head sells shares worth $405,264

Nima Ghamsari, the Head of Blend Labs , Inc. (NYSE:BLND), has sold shares of the company’s Class A Common Stock, according to a recent SEC filing. The transactions, which took place on June 12 and June 13, 2025, involved the sale of a total of 119,850 shares, generating approximately $405,264. The sale prices ranged from $3.3026 to $3.5167 per share. The timing of these sales coincides with BLND’s recent market performance, as the stock has declined about 14% in the past week and 34% over six months, according to InvestingPro data.

These transactions follow a series of acquisitions and disposals involving both Class A and Class B Common Stock. Ghamsari’s latest sales leave him with ownership of 6,065,937 shares of Class A Common Stock. While the transactions were significant, they did not alter his position as a director and officer at the company. InvestingPro analysis shows the company maintains strong liquidity with a current ratio of 2.41 and more cash than debt on its balance sheet. Analysts have set price targets ranging from $4 to $7, suggesting potential upside from current levels. Get access to the full BLND research report and 8 additional ProTips with an InvestingPro subscription.

In other recent news, Blend Labs, Inc. announced the appointment of Reva Rao as Head of Digital Transformation for Credit Unions, aimed at enhancing its offerings to credit unions with her extensive experience in the financial services sector. Additionally, Blend Labs is involved in a significant transaction, with Covius Services, LLC set to acquire Title365, a move expected to expand Covius’ title presence and technology platform integrations while allowing Blend to focus on its core software platform. Analyst firm Citizens JMP maintained its Market Outperform rating and $7.00 price target for Blend Labs, indicating confidence in the company’s intrinsic value and growth prospects despite a 16% year-to-date decline in stock performance. Meanwhile, Keefe, Bruyette & Woods (KBW) raised its price target for Blend Labs to $4.00 from $3.50, reflecting a more positive outlook on the company’s recent performance and future prospects. This adjustment is attributed to Blend Labs’ non-GAAP operating income surpassing estimates, despite revenue guidance falling short. JMP analysts also reiterated their Market Outperform rating, projecting significant revenue growth for Blend Labs in the coming years, with a steady non-GAAP EPS estimate for 2025 and beyond. These developments highlight Blend Labs’ strategic moves and the analysts’ confidence in its operational efficiency and growth potential.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.